News Link: Analysis Of More Than 50,000 Genomes Hints At New Disease-Causing GenessteemCreated with Sketch.

in #newslink8 years ago


Source

It wasn't that long ago that the very first human genome was sequenced (April 14, 2003), in what was a very expensive endeavor (the total project cost about 2.3 billion dollars, while the genome itself cost upwards of 100 million) involving a process called shotgun sequencing. Technology for genomic sequencing has increased by leaps and bounds since those days, and with it, the cost has drastically come down. Today it costs about $1000 to sequence (at least roughly) a human genome. As the price has come way way down (due to next-gen sequencing technologies like those done by illumina and pacific biosciences), a significantly greater number of genomes have been sequenced. People have been asking, " What is the point in sequencing more than one whole genome?" Thinking that the amount of data was just too great to deal with, and extract any useful information.

Well it seems all of this genomic data is finally beginning to pay out dividends. Researchers have described in a publication in the journal Science their identification of new genes which are potential evidence for various disease states. The study discussed not only common disease markers such as BRCA1 (a potential marker for breast cancer, and a select number of other cancers), but also new genetic markers for things like heart disease among others.

The researchers further explored the data to see whether or not the people whose genomes were being examined were being treated medically for the diseases which they have a genetic predisposition for, and found that in a relatively high number of cases they were not. The example provided in the write up was that 228 cases were found where the patients had a genetic condition causing elevated LDL levels (this condition is called familial hypercholesterolemia) the researchers reported that only 58% of these patients were on statins (cholesterol lowering medications) and less than 50% were receiving a sufficiently high dose.

As whole genome analysis becomes cheaper and cheaper, we may soon be approaching the point where each of us may want to provide our doctors with this information. We may be able to identify conditions, or genetic markers for increased likelihood of developing health issues long before they would be detectable by standard blood screening, through use of these big-data genetic analyses. It's a fascinating, and perhaps troubling path that our increased technological prowess is guiding us along. One which we may personally have to decide whether to embark upon much sooner than many may realize.

For more information check out this brief summary article:

http://www.sciencemag.org/news/2016/12/analysis-more-50000-genomes-hints-new-disease-causing-genes

Or dive into the primary publication here:

http://science.sciencemag.org/content/354/6319/aaf6814



If you like my work, please consider giving me a follow: @justtryme90. I am a PhD holding biochemist with a love for science. My future science blog posts will cover a range of topics in the biology/chemistry fields.

Thank you for your support of my work!

Sort:  

Coin Marketplace

STEEM 0.15
TRX 0.16
JST 0.028
BTC 67340.80
ETH 2419.68
USDT 1.00
SBD 2.35